Skip to content
GLP-1 Savers
Provider review

SkyRx review

Value Score63/100

SkyRx sells compounded semaglutide as either an injection or oral drops from $199 a month on a twelve-month prepaid plan, dispensed through FDA-registered 503B pharmacies, with tirzepatide still listed as coming soon.

By Grant Ashford, Founder & Pricing EditorUpdated

We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. It never changes the Value Score.

Advertised price

From $199/mo

From $199/mo (all doses, 12-month plan, compounded)

Pricing to watch. The $199 needs twelve months paid up front, which SkyRx's own footnote says and its headline does not. Two other things worth knowing before you compare it: tirzepatide is listed as coming soon rather than available, and SkyRx states plainly that GLP-1s are not yet offered in all 50 states without naming which.

How much does SkyRx cost?

The price SkyRx publishes is From $199/mo (all doses, 12-month plan, compounded). We flag this one to watch: confirm the ongoing rate with SkyRx before you count on it.

Semaglutide
From $199/mo (all doses, 12-month plan, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

SkyRx scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait80/100
Nationwide Availability45/100
Both Molecules62/100
Easy Cancellation25/100
Reputation65/100

What's good

  • Dispenses through US-based 503B compounding pharmacies registered with the FDA — the more heavily regulated of the two routes, and stated explicitly
  • Maintains LegitScript certification
  • Oral drops are priced the same as the injection at $199, so the needle-free route carries no premium
  • Says outright that GLP-1s are not available in every state rather than implying nationwide coverage

Read the fine print

  • The $199 rate requires a twelve-month subscription paid up front — there is no month-to-month figure published beside it
  • Tirzepatide is listed as coming soon in both injection and oral form, so semaglutide is the only real choice today
  • The states it does serve are never enumerated, so eligibility is unknown until you apply
  • Compounded only — no FDA-approved brand-name route

The bottom line

Best for: Someone committed to semaglutide for a year who wants a 503B pharmacy behind it.

For comparison, see CoreAge Rx, a featured partner (Value Score 81/100).

Programs to compare

Compare with other deals

The programs scoring closest to SkyRx, out of 428 others we track.

Shopping SkyRx against a specific rival? We put it head to head with our featured partner on CoreAge Rx vs SkyRx, and every program that undercuts or outscores it — starting with Nurx, the closest match on score — is ranked on the SkyRx alternatives ranking.

More programs we track (24)

395 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page come from SkyRx's own website; the Value Score is our editorial judgment per the methodology."% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on SkyRx's site. Not medical advice; see our disclosure.

Where SkyRx ranks

See the cheapest programs →

← Back to all deals